Breadcrumb

What's New at the RI-MUHC ?

RI-MUHC team detects impact of HIV antiretroviral therapy on the anti-tuberculosis immune response

Alveolar macrophages, cells important for protection from tuberculosis infection, are adversely impacted by...

The 2021 RI-MUHC Annual Report is online!

An invitation from Dr. Rhian Touyz

Discovery of mechanics of drug targets for COVID-19

Scientists unravel inner workings of cell receptors involved in inflammatory diseases

RI-MUHC researchers tackle COVID-19 vaccine hesitancy in adults and in children

Videos from projects led by Drs. Inés Colmegna and Moshe Ben-Shoshan are now available

RI-MUHC leads study of antiviral use in children hospitalized for influenza

Findings show that influenza antivirals are underutilized in Canadian pediatric hospitals, despite national clinical...

RI-MUHC scientist part of McGill team delivering World Alzheimer Report 2021

Alzheimer’s Disease International webinar launches report on World Alzheimer Day, September 21

RI-MUHC researcher Sasha Bernatsky leads nationwide COVID-19 vaccination study

New study will assess impact of the vaccines on Canadians with immune-mediated inflammatory disease

New cancer screening tool may help childhood cancer survivors

A novel cancer predisposition screening tool shows promise in helping doctors better predict which childhood cancer survivors may be at risk of developing...

Promising development in the fight with cancer using artificial intelligence

New privacy-preserving approach uses hospital based medical notes to refine predictions and prognosis in cancer...

Learn more about the RI-MUHC